The blockbuster GLP-1 drugs that have reshaped the treatment of diabetes and obesity may help prevent multiple substance use disorders — and reduce the tragic outcomes they cause, a large new study ...
Accumulating scientific evidence and industry interest from Eli Lilly, Altimmune and startup Baseline Therapeutics is driving further research on the therapeutic potential of GLP-1 receptor agonists ...
OSHKOSH, Wis. (WFRV) – ThedaCare and Apricity announced on Thursday that they would expand a significant program designed to ...
Global Impact Wellness launches in Baltimore, MD, offering mental health and substance use care focused on accessibility, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results